Article
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.
Nature - 1 Feb 2022
Liu Lihong, Iketani Sho, Guo Yicheng, Chan Jasper F-W, Wang Maple, Liu Liyuan, Luo Yang, Chu Hin, Huang Yiming, Nair Manoj S, Yu Jian, Chik Kenn K-H, Yuen Terrence T-T, Yoon Chaemin, To Kelvin K-W, Chen Honglin, Yin Michael T, Sobieszczyk Magdalena E, Huang Yaoxing, Wang Harris H, Sheng Zizhang, Yuen Kwok-Yung, Ho David D
Abstract excerpt
The B.1.1.529/Omicron variant of SARS-CoV-2 was only recently detected in southern Africa, but its subsequent spread has been extensive, both regionally and globally1. It is expected to become dominant in the coming weeks2, probably due to enhanced transmissibility. A striking feature of this variant is the large number of spike mutations3 that pose a threat to the efficacy of current COVID-19 vaccines and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.